Boiron SA (EPA:BOI)

Market Cap	451.42M +6.8%
Revenue (ttm)	504.86M +4.8%
Net Income	19.37M -18.2%
EPS	1.12 -18.2%
Shares Out	17.36M
PE Ratio	23.31
Forward PE	16.65
Dividend	1.20 (4.62%)
Ex-Dividend Date	Jun 3, 2025

Volume	836
Average Volume	1,261
Open	26.45
Previous Close	26.30
Day's Range	26.00 - 26.45
52-Week Range	20.85 - 32.25
Beta	0.26
RSI	32.70
Earnings Date	Mar 20, 2026

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics, and CBD-based products. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1932
• Employees: 2,736
• Stock Exchange: Euronext Paris
• Ticker Symbol: BOI

Financial Performance

In 2024, Boiron's revenue was 487.56 million, a decrease of -1.15% compared to the previous year's 493.25 million. Earnings were 11.34 million, a decrease of -68.36%.